跳至主要内容
临床试验/NCT05096351
NCT05096351招募中不适用

Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年6月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Presence of donor specific antibodies after venous allograft

研究概览

简要总结

The study investigators propose to perform a blood test before and after allograft placement in all patients receiving a cold-stored venous allografts at the University Hospital of Nîmes to study the occurrence of FVFA-related ASD in these patients.

The aim of this work is to characterize a possible immune reaction generated by the implantation of venous allografts prepared according to the BIOPROTEC method. In case of a proven immune reaction, the study will allow a modification of our current attitude and to exclude patients potentially eligible for renal transplantation at the time of venous allograft placement, or to perform in these patients an allo-compatibility test with the venous allograft preoperatively and thus protect these patients from an increased risk of subsequent organ transplant rejection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must be a member or beneficiary of a health insurance plan
  • Patients receiving a scheduled venous allograft within the CHU of Nîmes for an arterial bypass in the lower limb or an arteriovenous bypass in the upper limb within the framework of the creation of arteriovenous fistulas in dialysis patients, in the absence of available autologous venous material.

排除标准

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • The subject has already been included in the study
  • The subject refuses to participate
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient previously having received a venous allograft or organ transplant
  • Pregnant, parturient or breastfeeding patients

结局指标

主要结局

Presence of donor specific antibodies after venous allograft

时间窗: 1 month

Presence/absence of donner anti-HLA antibodies in patient blood, detected using Luminex assay

次要结局

  • Allograft anomalies linked to allograft rejection(6 month)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验